Chengdu Easton Biopharmaceuticals Co Ltd Free Cash Flow Generation Index
Chengdu Easton Biopharmaceuticals Co Ltd free cash flow generation index. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Free Cash Flow Generation Index of 0.60x as of September 2025. Free cash flow of CN¥37.04 Million represents 1% of operating cash flow (CN¥61.35 Million). Check 688513 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Free cash flow generation index of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. Historical FCF Generation Index trend for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Explore Chengdu Easton Biopharmaceuticals Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Chengdu Easton Biopharmaceuticals Co Ltd Free Cash Flow Generation Index by Year (2013–2025)
Chengdu Easton Biopharmaceuticals Co Ltd free cash flow generation index by year from 2013 to 2025. Year-by-year Free Cash Flow Generation Index for Chengdu Easton Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see 688513 cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | CN¥178.66 Million | CN¥264.94 Million | CN¥86.28 Million | ▲ +21.7% |
| 2024 | 0.55x | CN¥145.82 Million | CN¥263.24 Million | CN¥117.42 Million | ▲ +52.5% |
| 2023 | 0.36x | CN¥99.99 Million | CN¥275.25 Million | CN¥175.26 Million | ▲ +129.5% |
| 2022 | -1.23x | CN¥-187.38 Million | CN¥151.94 Million | CN¥339.33 Million | ▼ -67.5% |
| 2021 | -0.74x | CN¥-108.69 Million | CN¥147.60 Million | CN¥256.29 Million | ▼ -172.6% |
| 2020 | -0.27x | CN¥-42.28 Million | CN¥156.52 Million | CN¥198.81 Million | ▼ -182.5% |
| 2019 | 0.33x | CN¥46.42 Million | CN¥141.83 Million | CN¥95.41 Million | ▼ -39.5% |
| 2018 | 0.54x | CN¥90.15 Million | CN¥166.79 Million | CN¥76.63 Million | ▼ -26.1% |
| 2017 | 0.73x | CN¥62.68 Million | CN¥85.70 Million | CN¥23.02 Million | ▼ -12.1% |
| 2016 | 0.83x | CN¥88.23 Million | CN¥106.06 Million | CN¥17.83 Million | ▲ +178.0% |
| 2015 | 0.30x | CN¥15.13 Million | CN¥50.57 Million | CN¥35.43 Million | ▼ -43.3% |
| 2014 | 0.53x | CN¥24.67 Million | CN¥46.71 Million | CN¥22.04 Million | ▲ +130.9% |
| 2013 | -1.71x | CN¥-47.99 Million | CN¥28.12 Million | CN¥76.11 Million | — |